Salvage stereotactic radiosurgery for brain metastases

References

• Butowski N. Medical management of brain metastases. Neurosurg. Clin. North Am. 22(1), 27–36 (2011).
   PubMed Web of Science ®Google Scholar
• Gavrilovic IT, Posner JB. Brain metastases: epidemiology and pathophysiology. J. Neurooncol. 75(1), 5–14 (2005).
   PubMed Web of Science ®Google Scholar
• Soffietti R, Brain metastases: current management and new developments. Curr. Opin. Oncol. 20(6), 676–684 (2008).
   PubMed Web of Science ®Google Scholar
• Weinberg JS, Lang FF, Sawaya R. Surgical management of brain metastases. Curr. Oncol. Rep. 3(6), 476–83 (2001).
   PubMedGoogle Scholar
• Jemal A, Tiwari RC, Murray T et al. Cancer statistics, 2004. CA Cancer J. Clin. 54(1), 8–29 (2004).
   PubMed Web of Science ®Google Scholar
• Fox BD, Cheung VJ, Patel AJ et al. Epidemiology of metastatic brain tumors. Neurosurg. Clin. North Am. 22(1), 1–6 (2011).
   PubMed Web of Science ®Google Scholar
• Sloan AE, Nock CJ, Einstein DB. Diagnosis and treatment of melanoma brain metastasis: a literature review. Cancer Control 16(3), 248–55 (2009).
   PubMed Web of Science ®Google Scholar
• Harada Y, Nonomura N, Kondo M et al. Clinical study of brain metastasis of renal cell carcinoma. EurUrol 36(3), 230–235 (1999).
   Google Scholar
• Patanaphan V, Salazar OM. Colorectal cancer: metastatic patterns and prognosis. South Med. J. 86(1), 38–41 (1993).
   PubMed Web of Science ®Google Scholar
• Goetz P, Ebinu JO, Roberge D, Zadeh G. Current standards in the management of cerebral metastases. Int. J. Surg. Oncol. 2012,493–426 (2012).
   Google Scholar
• Gaspar L, Scott C, Rotman M et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int. J. Radiat. Oncol. Biol. Phys. 37(4), 745–751 (1997).
   PubMed Web of Science ®Google Scholar
• Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int. J. Radiat. Oncol. Biol. Phys. 70(2), 510–514 (2008).
   PubMed Web of Science ®Google Scholar
• Den RB, Andrews DW. Radiotherapy for brain metastases. Neurosurg. Clin. North Am. 22(1), 37–44 (2011).
   PubMed Web of Science ®Google Scholar
• Preusser M, Capper D, Ilhan-Mutlu A. et al. Brain metastases: pathobiology and emerging targeted therapies. Acta Neuropathol. 123(2), 205–222 (2012).
   PubMed Web of Science ®Google Scholar
• Soffietti R, Trevisan E, Rudà R. Targeted therapy in brain metastasis. Curr. Opin. Oncol. 24(6), 679–686 (2012).
   PubMed Web of Science ®Google Scholar
• Sperduto P, Chao ST, Sneed PK et al. Diagnosis-specific prognostic factors, indexes and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4259 patients. Int. J. Radiat. Oncol. Biol. Phys. 77(33), 655–661 (2010).
   PubMed Web of Science ®Google Scholar
• Sawaya R, Ligon BL, Bindal AK, Bindal RK, Hess KR. Surgical treatment of metastatic brain tumors. J. Neurooncol. 27(3), 269–277 (1996).
   PubMed Web of Science ®Google Scholar
• Patchell RA, Tibbs PA, Walsh JW et al. A randomized trial of surgery in the treatment of single metastases to the brain. N. Engl. J. Med. 322(8), 494–500 (1990).
   PubMed Web of Science ®Google Scholar
• Vecht CJ, Haaxma-Reiche H, Noordijk EM et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann. Neurol. 33(6), 583–590 (1993).
   PubMed Web of Science ®Google Scholar
• Patchell RA, Tibbs PA, Regine WF et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280(17), 1485–1489 (1998).
   PubMed Web of Science ®Google Scholar
• Soffietti R, Kocher M, Abacioglu UM et al. A European Organisation for Research and Treatment of Cancer Phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J. Clin. Oncol. 31(1), 65–72 (2013).
   PubMed Web of Science ®Google Scholar
• Antoni D, Clavier JB, Pop M, Schumacher C, Lefebvre F, Noël G. Institutional, retrospective analysis of 777 patients with brain metastases: treatment outcomes and diagnosis-specific prognostic factors. Int. J. Radiat. Oncol. Biol. Phys. 86(4),630–637 (2013).
   PubMed Web of Science ®Google Scholar
• Lwu S, Goetz P, Monsalves E et al. Stereotactic radiosurgery for the treatment of melanoma and renal cell carcinoma brain metastases. Oncol. Rep. 29(2), 407–412 (2013).
   PubMed Web of Science ®Google Scholar
• Tsao MN, Mehta MP, Whelan TJ et al. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma. Int. J. Radiat. Oncol. Biol. Phys. 1;63(1), 47–55 (2005).
   PubMed Web of Science ®Google Scholar
• Andrews DW, Scott CB, Sperduto PW et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomised trial. Lancet 363(9422), 1665–1672 (2004).
   PubMed Web of Science ®Google Scholar
• Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int. J. Radiat. Oncol. Biol. Phys. 45(2), 427–434 (1999).
   PubMed Web of Science ®Google Scholar
• Chang EL, Wefel JS, Hess KR et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 10(11), 1037–1044 (2009).
   PubMed Web of Science ®Google Scholar
• Aoyama H, Shirato H, Tago M et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295(21), 2483–2491 (2006).
   PubMed Web of Science ®Google Scholar
• Kocher M, Soffietti R, Abacioglu U et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952–26001 study. J. Clin. Oncol. 29(2), 134–141 (2011).
   PubMed Web of Science ®Google Scholar
• Rades D, Pluemer A, Veninga T, Dunst J, Schild SE. A boost in addition to whole- brain radiotherapy improves patient outcome after resection of one or two brain metastases (BM) in recursive partitioning analysis class 1 and 2 patients. Cancer 110(7), 1551–1559 (2007).
   PubMed Web of Science ®Google Scholar
• Roberge D, Parney I, Brown PD. Radiosurgery to the postoperative surgical cavity: who needs evidence? Int. J. Radiat. Oncol. Biol. Phys. 83(2), 486–493 (2012).
   PubMed Web of Science ®Google Scholar
• Roberge D, Petrecca K, El Refae M, Souhami L. Whole-brain radiotherapy and tumor bed radiosurgery following resection of solitary brain metastases. J. Neurooncol. 95(1), 95–99 (2009).
   PubMed Web of Science ®Google Scholar
• Roberge D, Souhami L. Tumor bed radiosurgery following resection of brain metastases: a review. Technol. Cancer Res. Treat. 9(6), 597–602 (2010).
   PubMed Web of Science ®Google Scholar
• Truong MT, St Clair EG, Donahue BR, Rush SC, Miller DC, Formenti SC. Results of surgical resection for progression of brain metastases previously treated by gamma knife radiosurgery. Neurosurgery 59(1), 86–97 (2006).
   PubMed Web of Science ®Google Scholar
• Vecil GG, Suki D, Maldaun MV, Lang FF, Sawaya R. Resection of brain metastases previously treated with stereotactic radiosurgery. J. Neurosurg. 102(2) 209–215 (2005).
   PubMed Web of Science ®Google Scholar
• Ammirati M, Cobbs CS, Linskey ME et al. The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline. J. Neurooncol. 96(1), 85–96 (2010).
   PubMed Web of Science ®Google Scholar
• Fonkem E, Uhlmann EJ, Floyd SR et al. Melanoma brain metastasis: overview of current management and emerging targeted therapies. Expert Rev. Neurother. 12(10), 1207–1215 (2012).
   PubMed Web of Science ®Google Scholar
• Abrey LE, Olson JD, Raizer JJ et al. A Phase II trial of temozolomide for patients with recurrent or progressive brain metastases. J. Neurooncol. 53(3), 259–265 (2001).
   PubMed Web of Science ®Google Scholar
• Hwu WJ, Lis E, Menell JH et al. Temozolomide plus thalidomide in patients with brain metastases from melanoma: a Phase II study. Cancer 103(12), 2590–2597 (2005).
   PubMed Web of Science ®Google Scholar
• Iwamoto FM, Omuro AM, Raizer JJ et al. A Phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases. J. Neurooncol. 87(1), 85–90 (2008).
   PubMed Web of Science ®Google Scholar
• Omuro AM, Raizer JJ, Demopoulos A, Malkin MG, Abrey LE. Vinorelbine combined with a protracted course of temozolomide for recurrent brain metastases: a Phase I trial. J. Neurooncol. 78(3), 277–280 (2006).
   PubMed Web of Science ®Google Scholar
• Bröcker EB, Bohndorf W, Kämpgen E, Trcka J, Messer P, Tilgen W. Fotemustine given simultaneously with total brain irradiation in multiple brain metastases of malignant melanoma: report on a pilot study. Melanoma Res. 6(5), 399–401 (1996).
   PubMed Web of Science ®Google Scholar
• Cooper JS, Steinfeld AD, Lerch IA. Cerebral metastases: value of reirradiation in selected patients. Radiology 174(3 Pt 1), 883–885 (1990).
   PubMed Web of Science ®Google Scholar
• Sadikov E, Bezjak A, Yi QL et al. Value of whole brain re-irradiation for brain metastases--single centre experience. Clin. Oncol. (R. Coll. Radiol.) 19(7), 532–538 (2007).
   PubMed Web of Science ®Google Scholar
• Wong WW, Schild SE, Sawyer TE, Shaw EG. Analysis of outcome in patients reirradiated for brain metastases. Int. J. Radiat. Oncol. Biol. Phys. 34(3), 585–590 (1996).
   PubMed Web of Science ®Google Scholar
• Davey P, O'Brien PF, Schwartz ML, Cooper PW. A Phase I/II study of salvage radiosurgery in the treatment of recurrent brain metastases. Br. J. Neurosurg. 8(6), 717–723 (1994).
   PubMed Web of Science ®Google Scholar
• Chao ST, Barnett GH, Vogelbaum MA et al. Salvage stereotactic radiosurgery effectively treats recurrences from whole-brain radiation therapy. Cancer 113(8), 2198–2204 (2008).
   PubMed Web of Science ®Google Scholar
• Loeffler JS, Kooy HM, Wen PY et al. The treatment of recurrent brain metastases with stereotactic radiosurgery. J. Clin. Oncol. 8(4), 576–582 (1990).
   PubMed Web of Science ®Google Scholar
• Noël G, Proudhom MA, Valery CA et al. Radiosurgery for re-irradiation of brain metastasis: results in 54 patients. Radiother. Oncol. 60(1), 61–67 (2001).
   PubMed Web of Science ®Google Scholar
• Sheehan J, Kondziolka D, Flickinger J, Lunsford LD. Radiosurgery for patients with recurrent small cell lung carcinoma metastatic to the brain: outcomes and prognostic factors. J. Neurosurg. 102( Suppl.), 247–254 (2005).
   PubMed Web of Science ®Google Scholar
• Akyurek S, Chang EL, Mahajan A et al. Stereotactic radiosurgical treatment of cerebral metastases arising from breast cancer. Am. J. Clin. Oncol. 30(3),310–314 (2007).
   PubMed Web of Science ®Google Scholar
• Kelly PJ, Lin NU, Claus EB, Quant EC, Weiss SE, Alexander BM. Salvage stereotactic radiosurgery for breast cancer brain metastases: outcomes and prognostic factors. Cancer 118(8), 2014–2020 (2012).
   PubMed Web of Science ®Google Scholar
• Harris S, Chan MD, Lovato JF et al. Gamma knife stereotactic radiosurgery as salvage therapy after failure of whole-brain radiotherapy in patients with small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 83(1),e53–e59 (2012).
   PubMed Web of Science ®Google Scholar
• Nakazaki K, Higuchi Y, Nagano O, Serizawa T. Efficacy and limitations of salvage gamma knife radiosurgery for brain metastases of small-cell lung cancer after whole-brain radiotherapy. Acta Neurochir. (Wien.) 155(1), 107–113 (2013).
   PubMed Web of Science ®Google Scholar
• Caballero JA, Sneed PK, Lamborn KR et al. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 83(1), 303–309 (2012).
   PubMed Web of Science ®Google Scholar
• Davey P, Schwartz M, Scora D, Gardner S, O'Brien PF. Fractionated (split dose) radiosurgery in patients with recurrent brain metastases: implications for survival. Br. J. Neurosurg. 21(5),491–495 (2007).
   PubMed Web of Science ®Google Scholar
• Chen JC, Petrovich Z, Giannotta SL, Yu C, Apuzzo ML. Radiosurgical salvage therapy for patients presenting with recurrence of metastatic disease to the brain. Neurosurgery 46(4), 860–866 (2000).
   PubMed Web of Science ®Google Scholar
• Kwon KY, Kong DS, Lee JI, Nam DH, Park K, Kim JH. Outcome of repeated radiosurgery for recurrent metastatic brain tumors. Clin. Neurol. Neurosurg. 109(2), 132–137 (2007).
   PubMed Web of Science ®Google Scholar
• Hanssens P, Karlsson B, Vashu R, Yeo TT, Beute G. Salvage treatment of distant recurrent brain metastases with Gamma Knife surgery. Acta Neurochir. (Wien.) 154(2), 285–290 (2012).
   PubMed Web of Science ®Google Scholar
• Shuto T, Fujino H, Inomori S, Nagano H. Repeated gamma knife radiosurgery for multiple metastatic brain tumours. Acta Neurochir. (Wien.) 146(9), 989–993 (2004).
   PubMed Web of Science ®Google Scholar
• Yamanaka K, Iwai Y, Yasui T et al. Gamma Knife radiosurgery for metastatic brain tumor: the usefulness of repeated Gamma Knife radiosurgery for recurrent cases. Stereotact. Funct. Neurosurg. 72( Suppl. 72), 73–80 (1999).
   PubMed Web of Science ®Google Scholar
• Gwak HS, Yoo HJ, Youn SM, Lee DH, Kim MS, Rhee CH. Radiosurgery for recurrent brain metastases after whole-brain radiotherapy: factors affecting radiation-induced neurological dysfunction. J. Korean Neurosurg. Soc. 45(5), 275–283 (2009).
   PubMed Web of Science ®Google Scholar